1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid

C40H53N11O5 — CID 86687188

IUPAC1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid
SMILESCC(C)(C)c1cc(NC(=O)N[C@H]2CC[C@@H](Oc3ccc4nnc(N5CCCCC5)n4c3)c3ccccc32)n(-c2cnn(CCCN3CCOCC3)c2)n1.O=CO
InChIInChI=1S/C39H51N11O3.CH2O2/c1-39(2,3)34-24-36(50(45-34)28-25-40-48(26-28)19-9-16-46-20-22-52-23-21-46)42-37(51)41-32-13-14-33(31-11-6-5-10-30(31)32)53-29-12-15-35-43-44-38(49(35)27-29)47-17-7-4-8-18-47;2-1-3/h5-6,10-12,15,24-27,32-33H,4,7-9,13-14,16-23H2,1-3H3,(H2,41,42,51);1H,(H,2,3)/t32-,33+;/m0./s1
InChIKeyZUAMTMGOFZCXDX-XWIRJDCTSA-N
MW767.94 g/mol
LogP5.60
Rot. Bonds10

About 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid

1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid (PubChem CID 86687188) has the molecular formula C40H53N11O5 and a molecular weight of 767.94 g/mol. Its IUPAC name is 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid.

Molecular Properties

Compound Name1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid
PubChem CID86687188
Molecular FormulaC40H53N11O5
Molecular Weight767.94 g/mol
Exact Mass767.42
IUPAC Name1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid
SMILESCC(C)(C)c1cc(NC(=O)N[C@H]2CC[C@@H](Oc3ccc4nnc(N5CCCCC5)n4c3)c3ccccc32)n(-c2cnn(CCCN3CCOCC3)c2)n1.O=CO
InChIInChI=1S/C39H51N11O3.CH2O2/c1-39(2,3)34-24-36(50(45-34)28-25-40-48(26-28)19-9-16-46-20-22-52-23-21-46)42-37(51)41-32-13-14-33(31-11-6-5-10-30(31)32)53-29-12-15-35-43-44-38(49(35)27-29)47-17-7-4-8-18-47;2-1-3/h5-6,10-12,15,24-27,32-33H,4,7-9,13-14,16-23H2,1-3H3,(H2,41,42,51);1H,(H,2,3)/t32-,33+;/m0./s1
InChIKeyZUAMTMGOFZCXDX-XWIRJDCTSA-N
XLogP5.60
TPSA169.20 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds10
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500767.94
LogP ≤ 55.60
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid?
The IUPAC name of 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid (CID 86687188) is 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid.
What is the SMILES notation for 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid?
The canonical SMILES for 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid is CC(C)(C)c1cc(NC(=O)N[C@H]2CC[C@@H](Oc3ccc4nnc(N5CCCCC5)n4c3)c3ccccc32)n(-c2cnn(CCCN3CCOCC3)c2)n1.O=CO.
What is the InChIKey of 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid?
The InChIKey is ZUAMTMGOFZCXDX-XWIRJDCTSA-N. The full InChI is InChI=1S/C39H51N11O3.CH2O2/c1-39(2,3)34-24-36(50(45-34)28-25-40-48(26-28)19-9-16-46-20-22-52-23-21-46)42-37(51)41-32-13-14-33(31-11-6-5-10-30(31)32)53-29-12-15-35-43-44-38(49(35)27-29)47-17-7-4-8-18-47;2-1-3/h5-6,10-12,15,24-27,32-33H,4,7-9,13-14,16-23H2,1-3H3,(H2,41,42,51);1H,(H,2,3)/t32-,33+;/m0./s1.
What are the key properties of 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid?
1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid has a molecular weight of 767.94 g/mol, XLogP of 5.60, 10 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-tert-butyl-1-[1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]pyrazol-5-yl]-3-[(1S,4R)-4-[(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea;formic acid is sourced from PubChem (CID 86687188), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).